Gabapentin Capsule
Product Images NDC 60760-818

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60760-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba (Gabapentin 60760 818 60)

This text appears to be a packaging label for Gabapentin capsules, which come in 100mg strength and are manufactured in India by a company called Sllidfiplflm. The capsules have a NDC (National Drug Code) number of 60760-818-60 and are available in quantities of 60. The label includes lot and expiration numbers for the capsules. There are also instructions to use as directed and to store at controlled room temperature.*

FDA Label Image

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

This is a formula to calculate the creatinine clearance rate (CLOr) for patients, using their age in years, weight in kilograms, and serum creatinine level in mg/dL. The formula includes adjustments for female patients (0.85 multiplier).*

FDA Label Image

Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

FDA Label Image

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

The text provides information on a 4-week fixed-dose period study, comparing two treatments (one being Gabapentin) to a placebo. The dosage for Gabapentin was 1800mg/day and 2400mg/day, and the study reports mean pain scores over a period of seven time points (baseline, 1-7).*

FDA Label Image

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

This is a graph showing the proportion of responders in patients suffering from Postherpetic Neuralgia (PHN) and achieving more than 50% reduction in pain score in controlled studies. The graph includes data from two studies, where study 2 has shown slightly higher response rates than study 1. The text also includes pricing for GBP 3600 for GBP, 1800 for Placebo, and GBP 2400 for an unspecified treatment related to the studies.*

FDA Label Image

Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.